Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study
A preliminary clinical trial analyzed brain activity flow patterns using evoked response potentials in youths with ADHD, autism spectrum dis…
-
FDA approval · 2024-06-26FDA Approved: OLANZAPINE — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for olanzapine from American Regent, Inc. for the generic product; the notice indicates a supplement…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder [Phase 2]
Phase 2 trial evaluating N-acetylcysteine for Bipolar Disorder has completed; results were posted on 2024-06-26.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
Ongoing clinical trial recruiting to develop a digital monitoring model to assess the mental state of hospitalized patients with severe ment…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs [NA]
Completed clinical trial examining how cognitive and metacognitive performance influences knowledge learning during therapeutic education pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-06-13FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: The CARE (Collaborative Adolescent Running Experience) Project [NA]
A completed clinical trial update from the CARE Project at the University of Michigan, investigating mood disorders (depression, anxiety, ma…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Investigation of the Effects of Family-Focused Therapy in the Early Period of Bipolar Disorder and Psychotic Disorder [NA]
The clinical trial investigating family-focused therapy in the early period of bipolar disorder and psychotic disorders has completed.
-
FDA approval · 2024-06-05FDA Approved: LAMOTRIGINE — Supplemental Application (Yiling Pharmaceutical, Inc.)
FDA approved Yiling Pharmaceutical's supplemental application to market Lamotrigine Extended-Release, a lamotrigine product.
-
FDA approval · 2024-05-29FDA Approved: OLANZAPINE — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc.'s supplemental application for olanzapine (ANDA201588). This action updates the approval for the generic product, p…
-
FDA approval · 2024-05-28FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for aripiprazole submitted by Alembic Pharmaceuticals Inc., authorizing a modification to the pr…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Technology Enhanced Family Treatment [Phase 1, Phase 2]
Phase 1/2 trial of Technology Enhanced Family Treatment for mood disorders and bipolar disorder completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China
ClinicalTrials.gov entry indicates a recruiting study led by Peking University to evaluate whether lithium can help prevent suicidality in a…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers [EARLY_Phase 1]
This update reports that the EARLY Phase 1 clinical trial evaluating the effects of cannabis on cognition and endocannabinoid levels in bipo…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Brain Stimulation and Cognitive Training - Efficacy [NA]
This clinical trial update reports efficacy results for a brain stimulation and cognitive training intervention in schizophrenia, schizoaffe…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: LIVES: Personalized Lifestyle Intervention for Patients With Depression [NA]
The LIVES trial investigates a personalized lifestyle intervention for adults with depression to help manage depressive symptoms and reduce …
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Stabilizing Mood and Sleep With Blue Blocking Eyewear in Bipolar Disorder [NA]
A clinical trial evaluating blue-blocking eyewear to stabilize mood and sleep in individuals with bipolar disorder, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder [NA]
A clinical trial is evaluating the effectiveness of vestibular stimulation for the depressive phase of bipolar disorder and is currently rec…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Study of a Vestibular Biomarker of Phase in Bipolar Disorder
An ongoing clinical trial is investigating a vestibular biomarker that may define mood phase in bipolar disorder.
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: A Study to Evaluate the Efficacy of VR for Bipolar Disorder [NA]
This clinical trial update reports a study evaluating the efficacy of virtual reality therapy for bipolar disorder, currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Honest Open Proud for Psychotic and Bipolar Disorder in Norway [NA]
An ongoing clinical trial update from Norway shows an Oslo University Hospital-sponsored study titled Honest Open Proud for psychotic disord…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of iloperidone for acute treatment of manic or mixed episodes in Bipolar I Disorde…
-
FDA approval · 2024-04-15FDA Approved: LAMOTRIGINE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for lamotrigine from Ajanta Pharma USA Inc.
-
FDA approval · 2024-04-11FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for lamotrigine (ANDA 079099), resulting in an approved change to the lamotrigine product u…
-
FDA approval · 2024-04-11FDA Approved: HALOPERIDOL — Original Application (Lifestar Pharma LLC)
FDA approved a generic haloperidol product from Lifestar Pharma LLC under an Original Application (ANDA 216918).